UnivTrevesV1, PascalFrancis, Corpus, bibRecord, 000855

Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie

Identifieur interne : 000855 ( PascalFrancis/Corpus ); précédent : 000854; suivant : 000856

Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie

Auteurs : R. Guenther ; V. Krenn ; T. H Upl

Source :

Zeitschrift für Rheumatologie : (Print) [ 0340-1855 ] ; 2008.

RBID : Pascal:08-0124913

Descripteurs français

Pascal (Inist)
- Polyarthrite rhumatoïde, Synovite, Echelle d'évaluation, Expression génique, Chronique.

English descriptors

KwdEn :
- Chronic, Evaluation scale, Gene expression, Rheumatoid arthritis, Synovitis.

Abstract

Inflammatory rheumatic diseases with their unclear aetiology are a challenge for the routine clinical practice. The dominating inflammatory processes with many facets of autoimmune phenomena have been extensively studied during the last decades. Modern high throughput technologies provide for the first time the opportunity to obtain an insight into the many different molecular aspects in one patient in parallel. Step by step, concepts can be developed to understand the relationships and interdependencies of the molecular processes and to place them in order of importance for each individual separately. Thus, studies have demonstrated that the risk of disease severity can be estimated and the response to therapy can be objectified based on molecular investigations. Exemplarily, the potential has been demonstrated that the therapeutic outcome towards a defined treatment may be predicted. Despite the high cost, it is becoming more and more obvious that an extensive increase of knowledge depends on the detection of a multitude of parameters, a task which will need to be accomplished in the near future.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0340-1855`
A02	`01`			`@0 ZRHMBQ`
A03		`1`		`@0 Z. Rheumatol. : (Print)`
A05				`@2 67`
A06				`@2 1`
A08	`01`	`1`	`GER`	`@1 Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie`
A11	`01`	`1`		`@1 GUENTHER (R.)`
A11	`02`	`1`		`@1 KRENN (V.)`
A11	`03`	`1`		`@1 HÄUPL (T.)`
A14	`01`			`@1 Institut für Pathologie, Charité Universitätsmedizin Berlin @3 DEU @Z 1 aut.`
A14	`02`			`@1 Institut für Pathologie @2 Trier @3 DEU @Z 2 aut.`
A14	`03`			`@1 Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin Berlin @3 DEU @Z 3 aut.`
A20				`@2 17-24 [7 p.]`
A21				`@1 2008`
A23	`01`			`@0 GER`
A24	`01`			`@0 eng`
A43	`01`			`@1 INIST @2 6410 @5 354000161940870020`
A44				`@0 0000 @1 © 2008 INIST-CNRS. All rights reserved.`
A45				`@0 43 ref.`
A47	`01`	`1`		`@0 08-0124913`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Zeitschrift für Rheumatologie : (Print)`
A66	`01`			`@0 DEU`
A68	`01`	`1`	`ENG`	`@1 Expression analyses for rheumatoid arthritis`
C01	`01`		`ENG`	@0 Inflammatory rheumatic diseases with their unclear aetiology are a challenge for the routine clinical practice. The dominating inflammatory processes with many facets of autoimmune phenomena have been extensively studied during the last decades. Modern high throughput technologies provide for the first time the opportunity to obtain an insight into the many different molecular aspects in one patient in parallel. Step by step, concepts can be developed to understand the relationships and interdependencies of the molecular processes and to place them in order of importance for each individual separately. Thus, studies have demonstrated that the risk of disease severity can be estimated and the response to therapy can be objectified based on molecular investigations. Exemplarily, the potential has been demonstrated that the therapeutic outcome towards a defined treatment may be predicted. Despite the high cost, it is becoming more and more obvious that an extensive increase of knowledge depends on the detection of a multitude of parameters, a task which will need to be accomplished in the near future.
C02	`01`	`X`		`@0 002B15D`
C03	`01`	`X`	`FRE`	`@0 Polyarthrite rhumatoïde @5 01`
C03	`01`	`X`	`ENG`	`@0 Rheumatoid arthritis @5 01`
C03	`01`	`X`	`SPA`	`@0 Poliartritis reumatoidea @5 01`
C03	`02`	`X`	`FRE`	`@0 Synovite @5 02`
C03	`02`	`X`	`ENG`	`@0 Synovitis @5 02`
C03	`02`	`X`	`SPA`	`@0 Sinovitis @5 02`
C03	`03`	`X`	`FRE`	`@0 Echelle d'évaluation @5 07`
C03	`03`	`X`	`ENG`	`@0 Evaluation scale @5 07`
C03	`03`	`X`	`SPA`	`@0 Escala evaluación @5 07`
C03	`04`	`X`	`FRE`	`@0 Expression génique @5 08`
C03	`04`	`X`	`ENG`	`@0 Gene expression @5 08`
C03	`04`	`X`	`SPA`	`@0 Expresión genética @5 08`
C03	`05`	`X`	`FRE`	`@0 Chronique @5 30`
C03	`05`	`X`	`ENG`	`@0 Chronic @5 30`
C03	`05`	`X`	`SPA`	`@0 Crónico @5 30`
C07	`01`	`X`	`FRE`	`@0 Maladie autoimmune @5 37`
C07	`01`	`X`	`ENG`	`@0 Autoimmune disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Enfermedad autoinmune @5 37`
C07	`02`	`X`	`FRE`	`@0 Rhumatisme inflammatoire @5 38`
C07	`02`	`X`	`ENG`	`@0 Inflammatory joint disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Reumatismo inflamatorio @5 38`
C07	`03`	`X`	`FRE`	`@0 Pathologie du système ostéoarticulaire @5 39`
C07	`03`	`X`	`ENG`	`@0 Diseases of the osteoarticular system @5 39`
C07	`03`	`X`	`SPA`	`@0 Sistema osteoarticular patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Immunopathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Immunopathology @5 40`
C07	`04`	`X`	`SPA`	`@0 Inmunopatología @5 40`
N21				`@1 070`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 08-0124913 INIST
ET :	(Expression analyses for rheumatoid arthritis)
GT :	Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie
AU :	GUENTHER (R.); KRENN (V.); HÄUPL (T.)
AF :	Institut für Pathologie, Charité Universitätsmedizin Berlin/Allemagne (1 aut.); Institut für Pathologie/Trier/Allemagne (2 aut.); Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin Berlin/Allemagne (3 aut.)
DT :	Publication en série; Niveau analytique
SO :	Zeitschrift für Rheumatologie : (Print); ISSN 0340-1855; Coden ZRHMBQ; Allemagne; Da. 2008; Vol. 67; No. 1; 17-24 [7 p.]; Abs. anglais; Bibl. 43 ref.
LA :	Allemand
EA :	Inflammatory rheumatic diseases with their unclear aetiology are a challenge for the routine clinical practice. The dominating inflammatory processes with many facets of autoimmune phenomena have been extensively studied during the last decades. Modern high throughput technologies provide for the first time the opportunity to obtain an insight into the many different molecular aspects in one patient in parallel. Step by step, concepts can be developed to understand the relationships and interdependencies of the molecular processes and to place them in order of importance for each individual separately. Thus, studies have demonstrated that the risk of disease severity can be estimated and the response to therapy can be objectified based on molecular investigations. Exemplarily, the potential has been demonstrated that the therapeutic outcome towards a defined treatment may be predicted. Despite the high cost, it is becoming more and more obvious that an extensive increase of knowledge depends on the detection of a multitude of parameters, a task which will need to be accomplished in the near future.
CC :	002B15D
FD :	Polyarthrite rhumatoïde; Synovite; Echelle d'évaluation; Expression génique; Chronique
FG :	Maladie autoimmune; Rhumatisme inflammatoire; Pathologie du système ostéoarticulaire; Immunopathologie
ED :	Rheumatoid arthritis; Synovitis; Evaluation scale; Gene expression; Chronic
EG :	Autoimmune disease; Inflammatory joint disease; Diseases of the osteoarticular system; Immunopathology
SD :	Poliartritis reumatoidea; Sinovitis; Escala evaluación; Expresión genética; Crónico
LO :	INIST-6410.354000161940870020
ID :	08-0124913

Links to Exploration step

Pascal:08-0124913

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="GER" level="a">Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie</title>
<author><name sortKey="Guenther, R" sort="Guenther, R" uniqKey="Guenther R" first="R." last="Guenther">R. Guenther</name>
<affiliation><inist:fA14 i1="01"><s1>Institut für Pathologie, Charité Universitätsmedizin Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krenn, V" sort="Krenn, V" uniqKey="Krenn V" first="V." last="Krenn">V. Krenn</name>
<affiliation><inist:fA14 i1="02"><s1>Institut für Pathologie</s1>
<s2>Trier</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="H Upl, T" sort="H Upl, T" uniqKey="H Upl T" first="T." last="H Upl">T. H Upl</name>
<affiliation><inist:fA14 i1="03"><s1>Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin Berlin</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0124913</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0124913 INIST</idno>
<idno type="RBID">Pascal:08-0124913</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000855</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="GER" level="a">Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie</title>
<author><name sortKey="Guenther, R" sort="Guenther, R" uniqKey="Guenther R" first="R." last="Guenther">R. Guenther</name>
<affiliation><inist:fA14 i1="01"><s1>Institut für Pathologie, Charité Universitätsmedizin Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krenn, V" sort="Krenn, V" uniqKey="Krenn V" first="V." last="Krenn">V. Krenn</name>
<affiliation><inist:fA14 i1="02"><s1>Institut für Pathologie</s1>
<s2>Trier</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="H Upl, T" sort="H Upl, T" uniqKey="H Upl T" first="T." last="H Upl">T. H Upl</name>
<affiliation><inist:fA14 i1="03"><s1>Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin Berlin</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Zeitschrift für Rheumatologie : (Print)</title>
<title level="j" type="abbreviated">Z. Rheumatol. : (Print)</title>
<idno type="ISSN">0340-1855</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Zeitschrift für Rheumatologie : (Print)</title>
<title level="j" type="abbreviated">Z. Rheumatol. : (Print)</title>
<idno type="ISSN">0340-1855</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chronic</term>
<term>Evaluation scale</term>
<term>Gene expression</term>
<term>Rheumatoid arthritis</term>
<term>Synovitis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Polyarthrite rhumatoïde</term>
<term>Synovite</term>
<term>Echelle d'évaluation</term>
<term>Expression génique</term>
<term>Chronique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Inflammatory rheumatic diseases with their unclear aetiology are a challenge for the routine clinical practice. The dominating inflammatory processes with many facets of autoimmune phenomena have been extensively studied during the last decades. Modern high throughput technologies provide for the first time the opportunity to obtain an insight into the many different molecular aspects in one patient in parallel. Step by step, concepts can be developed to understand the relationships and interdependencies of the molecular processes and to place them in order of importance for each individual separately. Thus, studies have demonstrated that the risk of disease severity can be estimated and the response to therapy can be objectified based on molecular investigations. Exemplarily, the potential has been demonstrated that the therapeutic outcome towards a defined treatment may be predicted. Despite the high cost, it is becoming more and more obvious that an extensive increase of knowledge depends on the detection of a multitude of parameters, a task which will need to be accomplished in the near future.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0340-1855</s0>
</fA01>
<fA02 i1="01"><s0>ZRHMBQ</s0>
</fA02>
<fA03 i2="1"><s0>Z. Rheumatol. : (Print)</s0>
</fA03>
<fA05><s2>67</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="GER"><s1>Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>GUENTHER (R.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>KRENN (V.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HÄUPL (T.)</s1>
</fA11>
<fA14 i1="01"><s1>Institut für Pathologie, Charité Universitätsmedizin Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Institut für Pathologie</s1>
<s2>Trier</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin Berlin</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s2>17-24 [7 p.]</s2>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>GER</s0>
</fA23>
<fA24 i1="01"><s0>eng</s0>
</fA24>
<fA43 i1="01"><s1>INIST</s1>
<s2>6410</s2>
<s5>354000161940870020</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>43 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0124913</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Zeitschrift für Rheumatologie : (Print)</s0>
</fA64>
<fA66 i1="01"><s0>DEU</s0>
</fA66>
<fA68 i1="01" i2="1" l="ENG"><s1>Expression analyses for rheumatoid arthritis</s1>
</fA68>
<fC01 i1="01" l="ENG"><s0>Inflammatory rheumatic diseases with their unclear aetiology are a challenge for the routine clinical practice. The dominating inflammatory processes with many facets of autoimmune phenomena have been extensively studied during the last decades. Modern high throughput technologies provide for the first time the opportunity to obtain an insight into the many different molecular aspects in one patient in parallel. Step by step, concepts can be developed to understand the relationships and interdependencies of the molecular processes and to place them in order of importance for each individual separately. Thus, studies have demonstrated that the risk of disease severity can be estimated and the response to therapy can be objectified based on molecular investigations. Exemplarily, the potential has been demonstrated that the therapeutic outcome towards a defined treatment may be predicted. Despite the high cost, it is becoming more and more obvious that an extensive increase of knowledge depends on the detection of a multitude of parameters, a task which will need to be accomplished in the near future.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B15D</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Polyarthrite rhumatoïde</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Rheumatoid arthritis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Poliartritis reumatoidea</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Synovite</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Synovitis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Sinovitis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Echelle d'évaluation</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Evaluation scale</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Escala evaluación</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Expression génique</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Gene expression</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Expresión genética</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chronique</s0>
<s5>30</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chronic</s0>
<s5>30</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Crónico</s0>
<s5>30</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Maladie autoimmune</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Autoimmune disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Enfermedad autoinmune</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Rhumatisme inflammatoire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Inflammatory joint disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Reumatismo inflamatorio</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie du système ostéoarticulaire</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Diseases of the osteoarticular system</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema osteoarticular patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>070</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 08-0124913 INIST</NO>
<ET>(Expression analyses for rheumatoid arthritis)</ET>
<GT>Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie</GT>
<AU>GUENTHER (R.); KRENN (V.); HÄUPL (T.)</AU>
<AF>Institut für Pathologie, Charité Universitätsmedizin Berlin/Allemagne (1 aut.); Institut für Pathologie/Trier/Allemagne (2 aut.); Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin Berlin/Allemagne (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Zeitschrift für Rheumatologie : (Print); ISSN 0340-1855; Coden ZRHMBQ; Allemagne; Da. 2008; Vol. 67; No. 1; 17-24 [7 p.]; Abs. anglais; Bibl. 43 ref.</SO>
<LA>Allemand</LA>
<EA>Inflammatory rheumatic diseases with their unclear aetiology are a challenge for the routine clinical practice. The dominating inflammatory processes with many facets of autoimmune phenomena have been extensively studied during the last decades. Modern high throughput technologies provide for the first time the opportunity to obtain an insight into the many different molecular aspects in one patient in parallel. Step by step, concepts can be developed to understand the relationships and interdependencies of the molecular processes and to place them in order of importance for each individual separately. Thus, studies have demonstrated that the risk of disease severity can be estimated and the response to therapy can be objectified based on molecular investigations. Exemplarily, the potential has been demonstrated that the therapeutic outcome towards a defined treatment may be predicted. Despite the high cost, it is becoming more and more obvious that an extensive increase of knowledge depends on the detection of a multitude of parameters, a task which will need to be accomplished in the near future.</EA>
<CC>002B15D</CC>
<FD>Polyarthrite rhumatoïde; Synovite; Echelle d'évaluation; Expression génique; Chronique</FD>
<FG>Maladie autoimmune; Rhumatisme inflammatoire; Pathologie du système ostéoarticulaire; Immunopathologie</FG>
<ED>Rheumatoid arthritis; Synovitis; Evaluation scale; Gene expression; Chronic</ED>
<EG>Autoimmune disease; Inflammatory joint disease; Diseases of the osteoarticular system; Immunopathology</EG>
<SD>Poliartritis reumatoidea; Sinovitis; Escala evaluación; Expresión genética; Crónico</SD>
<LO>INIST-6410.354000161940870020</LO>
<ID>08-0124913</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000855 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000855 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Rhénanie
   |area=    UnivTrevesV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:08-0124913
   |texte=   Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Jul 22 16:29:01 2017. Site generation: Wed Feb 28 14:55:37 2024

	Serveur d'exploration sur l'Université de Trèves
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur l'Université de Trèves

Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie

Expressionsanalysen bei der rheumatoiden Arthritis : Rheumapathologie

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri